Steve Hays, MD

Medical director of Lung Transplantation, pulmonologist

Dr. Steven Hays is a pulmonologist and medical director of the Lung Transplant Program, known for accepting patients with complex conditions and maintaining survival rates consistently higher than the national average. His expertise is in the treatment of patients with end-stage lung disease who go on to get lung transplants. Conditions treated include cystic fibrosis, emphysema associated with alpha-1 antitrypsin deficiency, and interstitial lung disease. His key area of research is studying the mechanisms of airway remodeling in the transplanted lung.

Hays earned a medical degree at the University of Kansas in 1995. He completed a residency in internal medicine at the University of Kansas Medical Center, where he served as chief resident, and a fellowship in pulmonary and critical care medicine at UCSF. He also completed a lung transplant fellowship at Stanford University Hospital.


ILD Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-2577
Fax: (415) 353-8944

Lung Transplant Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (exact times vary depending on number of physicians in clinic)

Board Certification

Critical Care Medicine, American Board of Internal Medicine
Pulmonary Disease, American Board of Internal Medicine

Academic Title


More about Steve Hays

Additional Languages



University of Kansas School of Medicine 1995


University of Kansas Medical Center, Internal Medicine 1998


UCSF Medical Center, Pulmonary Medicine 2003
Stanford Hospital and Clinics, Lung Transplant 2004

Selected Research and Publications

  1. Kozuch JM, Feist A, Yung G, Awdishu L, Hays S, Singer JP, Florez R. Low Dose Posaconazole Delayed Release Tablets for Fungal Prophylaxis in Lung Transplant Recipients. Clin Transplant. 2018 May 28; e13300.
  2. Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, Sciurba FC, Shah PL, Wahidi MM, de Oliveira HG, Morrissey B, Cardoso PFG, Hays S, Majid A, Pastis N, Kopas L, Vollenweider M, McFadden PM, Machuzak M, Hsia DW, Sung A, Jarad N, Kornaszewska M, Hazelrigg S, Krishna G, Armstrong B, Shargill NS, Slebos DJ. A Multicenter RCT of Zephyr® Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE). Am J Respir Crit Care Med. 2018 May 22.
  3. Singer JP, Soong A, Bruun A, Bracha A, Chin G, Hays SR, Kukreja J, Rigler J, Golden JA, Greenland JR, Garvey C. A mobile health technology enabled home-based intervention to treat frailty in adult lung transplant candidates: A pilot study. Clin Transplant. 2018 May 09; e13274.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.